Gwyntwr1386 Science Journal

1. Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin.Garg P, Morris P, Fazlanie AL, Vijayan S, Dancso B, Dastidar AG, Plein S, Mueller C, Haaf P. Intern Emerg Med. 2017 Mar;12(2):147-155. 2 . Rapid and Sensitive Detection of Cardiac Troponin I for Point-of-Care Tests Based on Red Fluorescent MicrospheresYanxue Cai, Keren Kang, Qianru Li, Yu Wang, Xiaowei He Molecules. 2018 May; 23(5): 1102 3. How to choose a point-of-care testing for troponin.Lin YH, Zhang Y, Liu YT, Cui K, Kang JS, Zhou Z.J Clin Lab Anal. 2020 Jul;34(7):e23263. 4. Pedro A. (2020) The use of Multi-compartment Compliance Aids (MCAs) in Pharmacies in England and North Wales. Pre-prints, doi: 10.20944/preprints202007.0541.v1 5. Does use of point-of-care testing improve cost-effectiveness of the NHS Health Check programme in the primary care setting? A cost-minimisation analysis. Austen El-Osta, Maria Woringer, Elena Pizzo, Talitha Verhoef, Claire Dickie, Melody Z Ni,

“An E-Medicine Delivery and Treatment Monitoring Service For Patients With Heart Disease In The NHS” - Project proposal ISSN 2753-8176 (online) (DOI:10.13140/RG.2.2.34395.03360) Ana Pedro1 1Gwyntwr1386 Healthcare CIC, Regus Chester Business Park, Heronsway, Chester, CH49QR, UK. C oronary heart disease (CHD) is the most common type of heart and circulatory disease and the most common cause of heart attack and the single biggest killer worldwide. However, survival of post-myorcardial infarction can be improved if adherence to secondary prevention medication is maintained. Patient care can also be improved by monitoring cardiac troponin complex proteins which are well established as diagnostic biomarkers of myocardial injury in the context of CHD (1). These troponins are routinely screened for in a a point-of-care (POC) reliable lateral flow immunoassay in the NHS (2,3). Also, most MCA (medicine-compliance aids) patients are elderly and suffer of combined cardiovascular di